Rob Puopolo, a partner in Goodwin’s Life Sciences practice, focuses his practice on representing public and privately held life sciences companies , as well as the venture capital firms, hedge funds and investment banks that focus on these companies.

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Mr. Puopolo advises life sciences companies as general outside counsel on a variety of transactions. In addition to day-to-day representation and strategic advice to his clients, he regularly handles IPOs and public offerings, mergers and acquisitions, joint ventures and other strategic collaborations. 

A selection of Mr. Puopolo’s recent representations include:

  • CRISPR Therapeutics in its $56 million initial public offering, $200 million and $130 million public follow-on offerings
  • CRISPR Therapeutics in its, collaboration with ViaCyte, focused on stem cell therapies for the treatment of diabetes
  • Broadfin Capital on its investment in BioDelivery Sciences International’s $50 million public equity financing
  • Surface Oncology in its $119.5 million initial public offering
  • Goldman Sachs as lead underwriter in Arvinas’ $120 million initial public offering 
  • Pablo Legorreta, founder and CEO of Royalty Pharma, as lead investor in ITBMed’s $67 million equity financing round
  • Ra Pharmaceuticals in its $58 million public follow-on offering
  • Ginkgo Bioworks in its joint venture with Bayer focused on plant microbiome, with an initial investment of $100 million
  • Lysosomal Therapeutics, Inc. (LTI) in its exclusive option arrangement with Allergan plc
  • Versant Ventures in launching BlueRock Therapeutics, a next-generation regenerative medicine company, where Bayer and Versant are committing $225 million
  • Padlock Therapeutics in its sale to Bristol-Myers Squibb, with $225 million in upfront and near-term payments
  • F-star Alpha in connection with its exclusive option agreement with Bristol-Myers Squibb
  • CRISPR Therapeutics in its collaboration with Bayer, valued up to $335 million up front, and $38 million Series B financing
  • Alkermes in the sale of its manufacturing facility and the manufacturing and royalty revenue associated with products manufactured at the facility and global rights to Recro Pharma, Inc., for $170 million
  • Guerbet in a $270 million acquisition of Mallinckrodt's Contrast Media and Delivery Systems business
Professional Experience

Prior to rejoining Goodwin in 2014, Mr. Puopolo was a shareholder at Greenberg Traurig in Boston, where he served as co-chair of its emerging technology group. He has been licensed (inactive) in Massachusetts as a certified public accountant.

Recognition

Mr. Puopolo has been repeatedly recognized as a Massachusetts Super Lawyer “Rising Star” by Law & Politics and Boston magazines. In law school, he was a member of the Suffolk University Transnational Law Review.

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 1998
Suffolk University School of Law
(cum laude)
B.A., 1993
Northeastern University

Admissions

Bar

Massachusetts
Get In Touch
German Translation
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师